Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 1997

View Archived Issues

Chiroscience discloses cytokine inhibitors

Leukotriene antagonists from Pfizer

Fujisawa reports selective COX-2 inhibitors

Nissan Chem. reveals new antidiabetic agents

Agents with antiinflammatory, immunosuppressive, antiproliferative effects from Roussel Uclaf

Cantab: Q1 1997 highlights

Hayashibara discovers human protein that induces IFN-gamma production

Sagami prepares new anti-H. pylori agents

Coulter: Q1 1997 highlights

New HIV protease inhibitors reported by Kissei

Otsuka reports analgesic agents

Celtrix: Fiscal year-end highlights

Liposomal 5-ASA for IBD: pharmacokinetics in rat jejunum

Promising initial clinical results for mycophenolate in IBD

Favorable clinical results with rifaximin in steroid-resistant ulcerative colitis

Nycomed, SmithKline Beecham refocus hemoregulatory peptide program

Safety and efficacy of oral budesonide (Budenofalk) in Crohn's disease and collagenous colitis

ProCyte launches GraftCyte products

Oral methotrexate for severe IBD in children

Retrospective evaluation of immunosuppressive therapy for pediatric IBD

AltaRex initiates U.S. phase IIb trial with Ovarex

Use of labetalol in renal transplant patients discouraged

Merck & Co. acquires majority share of Gentili

Losartan effective in chronic renal allograft rejection

Promising results with DuPont Merck's DMP-266 reported

FLAP inhibitor from Bayer inhibits allergen-induced bronchoconstriction in atopic asthmatics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...